---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-266779"
form_type: "8-K"
ticker: "IDXX"
cik: "0000874716"
company_name: "IDEXX LABORATORIES INC /DE"
filed_at: "2022-10-21T23:59:59+00:00"
generated_at: "2026-06-23T02:07:41.308402+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# IDEXX amends credit agreement, adds $250M term loan and SOFR conversion

## Summary
- Borrowed $250M incremental term loan on Oct 20, 2022 under amended credit facility.
- Total capacity increased to up to $1.5B with option for additional $250M term/revolver.
- Existing LIBOR-based borrowings will convert to SOFR-based upon interest period expiry.
- Interest rates based on SOFR plus margin 0.875%-1.375% depending on leverage ratio.
- Covenants reaffirmed; no event of default; obligations remain in full force.

## SEC filing metadata
- accession: 0001193125-22-266779
- form_type: 8-K
- ticker: IDXX
- cik: 0000874716
- company_name: IDEXX LABORATORIES INC /DE
- filed_at: 2022-10-21T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/874716/000119312522266779/0001193125-22-266779-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/874716/000119312522266779/d389616d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-266779
- JSON: https://secwatch.observer/filing/0001193125-22-266779.json
- Plain text: https://secwatch.observer/filing/0001193125-22-266779.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.